The ‘QUAD SHOT’—a phase II study of palliative radiotherapy for incurable head and neck cancer
June Corry(St Vincent's Hospital Melbourne), Sandro Porceddu(Peter MacCallum Cancer Centre), Ieta D' Costa(Radiation Oncology Associates), Alvin Milner(MRC Clinical Trials Unit at UCL), Lester J. Peters(Peter MacCallum Cancer Centre), Helen Fawns, Danny Rischin(Peter MacCallum Cancer Centre)
Cited by 258
Related Papers
Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|1990|1.4k
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships
|International Journal of Radiation Oncology*Biology*Physics|1982|842
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741
Prognostic Significance of [<sup>18</sup>F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
|Journal of Clinical Oncology|2006|543